Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 242 entries
View as:

A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT04084158 Org: User:
Start: 09/07/19 End: 12/30/21 Due: 12/30/22

Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05991947 Org: User:
Start: 03/01/21 End: 12/31/25 Due: 12/31/26

a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .

Phase: N/A Priority: Normal
NCT ID: NCT07035808 Org: User:
Start: 07/01/25 End: 12/31/29 Due: 12/31/30

DEB-TACE Treatment in 367 Liver Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03317483 Org: User:
Start: 11/12/15 End: 12/28/16 Due: 12/28/17

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05053386 Org: User:
Start: 10/31/21 End: 04/30/23 Due: 04/30/24

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06437678 Org: User:
Start: 05/27/24 End: 02/28/26 Due: 02/28/27

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03618810 Org: User:
Start: 01/20/19 End: 12/31/21 Due: 12/31/22

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03756090 Org: User:
Start: 12/01/18 End: 11/30/20 Due: 11/30/21

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02649101 Org: User:
Start: 10/31/15 End: 10/31/17 Due: 10/31/18

The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06103214 Org: User:
Start: 01/01/17 End: 01/31/23 Due: 01/31/24

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01258192 Org: User:
Start: 01/31/11 End: 10/31/12 Due: 10/31/13

Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04190745 Org: User:
Start: 11/29/19 End: 06/30/24 Due: 06/30/25

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03025958 Org: User:
Start: 03/13/17 End: 12/30/23 Due: 12/30/24

Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT04657848 Org: User:
Start: 06/01/20 End: 06/01/23 Due: 06/01/24

Dendrobium Huoshanense Suppository in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05079438 Org: User:
Start: 09/07/21 End: 08/31/24 Due: 08/31/25

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04972448 Org: User:
Start: 07/31/21 End: 11/30/25 Due: 11/30/26

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT06349044 Org: User:
Start: 03/20/24 End: 12/31/25 Due: 12/31/26

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05075512 Org: User:
Start: 09/01/21 End: 08/31/26 Due: 08/31/27

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06364826 Org: User:
Start: 04/22/24 End: 04/22/26 Due: 04/22/27

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04049344 Org: User:
Start: 08/15/19 End: 12/31/21 Due: 12/31/22

Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC

Phase: N/A Priority: Normal
NCT ID: NCT03876587 Org: User:
Start: 03/31/19 End: 12/31/20 Due: 12/31/21

Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT06419140 Org: User:
Start: 06/01/24 End: 12/31/25 Due: 12/31/26

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03647514 Org: User:
Start: 12/01/18 End: 09/30/20 Due: 09/30/21

Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens

Phase: N/A Priority: Normal
NCT ID: NCT06572319 Org: User:
Start: 09/01/24 End: 12/31/26 Due: 12/31/27

A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure

Phase: N/A Priority: Normal
NCT ID: NCT05489926 Org: User:
Start: 08/16/22 End: 12/31/24 Due: 12/31/25